Fibromialgia: revisión de tratamientos y suplementos basada en la evidencia
Tratamiento establecido
Las recomendaciones de la AAFP consideran el ejercicio aeróbico como la intervención no farmacológica con mayor respaldo científico. Se recomienda combinarlo con terapia cognitivo-conductual y, cuando esté clínicamente indicado, con medicamentos como duloxetina, pregabalina o amitriptilina.
Una revisión sistemática y metaanálisis de gran tamaño publicado en JAMA Internal Medicine encontró evidencia de alta calidad a favor de la terapia cognitivo-conductual para reducir el dolor a corto plazo, así como de los antidepresivos y depresores del sistema nervioso central para mejorar el dolor y la calidad de vida a mediano plazo.
Un metaanálisis en red encontró que la amitriptilina se asoció con las mayores mejorías en el sueño, la fatiga y la calidad de vida, mientras que la duloxetina produjo las mayores reducciones del dolor y los síntomas depresivos.
Suplementos
Varios suplementos tienen mayor respaldo científico que el GABA oral, la L-teanina o el CBD para el manejo de los síntomas de la fibromialgia. Las opciones con mayor evidencia incluyen coenzima Q10, magnesio, vitamina D, melatonina, S-adenosilmetionina, acetil-L-carnitina y probióticos. Sin embargo, ninguno se considera un tratamiento de primera línea y la calidad general de la evidencia continúa siendo, como máximo, moderada.
Coenzima Q10
La coenzima Q10 presenta algunos de los datos más consistentes de ensayos clínicos aleatorizados entre los suplementos. En un estudio, 300 mg diarios durante 40 días redujeron significativamente el dolor, la fatiga y el cansancio matutino en comparación con placebo.
Un estudio cruzado que utilizó 200 mg dos veces al día informó una mejoría aproximada del 24%–37% en los resultados relacionados con el dolor y una reducción cercana al 22% en la fatiga.
La adición de coenzima Q10 a pregabalina también redujo significativamente el dolor y la ansiedad en comparación con pregabalina sola, lo que sugiere una posible función como tratamiento complementario.
Magnesio
El citrato de magnesio, administrado a una dosis de 300 mg diarios durante ocho semanas, redujo significativamente el número de puntos sensibles, el índice de puntos sensibles, las puntuaciones del Cuestionario de Impacto de la Fibromialgia y los síntomas depresivos en un ensayo aleatorizado de 60 pacientes.
La combinación de magnesio y amitriptilina mejoró todos los parámetros evaluados y superó los resultados obtenidos con cualquiera de las dos intervenciones por separado.
Los pacientes con fibromialgia han presentado con frecuencia concentraciones séricas o eritrocitarias de magnesio más bajas. Los niveles reducidos se han correlacionado con mayor dolor, alteraciones del sueño y limitación funcional.
La evidencia sobre el magnesio para el dolor crónico en general continúa siendo inconclusa, aunque los resultados específicos para la fibromialgia son más alentadores.
Vitamina D
Los resultados relacionados con la vitamina D son mixtos. Un ensayo aleatorizado informó que corregir la deficiencia de vitamina D con 1,200–2,400 UI diarias durante 25 semanas redujo significativamente el dolor medido mediante escala visual analógica y la fatiga matutina.
Otro estudio que utilizó 50,000 UI semanales durante 12 semanas no encontró mejorías significativas en el dolor ni en las puntuaciones del Cuestionario de Impacto de la Fibromialgia.
Un metaanálisis de ocho estudios con 694 participantes encontró mejorías en la función física y en las puntuaciones del Cuestionario de Impacto de la Fibromialgia, pero no en el dolor medido mediante escala visual analógica.
Por lo tanto, la suplementación con vitamina D probablemente beneficie principalmente a los pacientes con una deficiencia documentada.
Melatonina
La melatonina, administrada en dosis de 3–6 mg al acostarse, mejoró el dolor, el sueño, el número de puntos sensibles y las puntuaciones del Cuestionario de Impacto de la Fibromialgia en varios estudios.
Una revisión sistemática de 2026 sobre melatonina para el dolor musculoesquelético encontró mejorías modestas en el dolor crónico y la calidad del sueño, aunque los cambios no alcanzaron de manera consistente los umbrales mínimos de importancia clínica.
La melatonina debe considerarse principalmente como un tratamiento complementario para pacientes con síntomas de fibromialgia en los que predominan las alteraciones del sueño.
GABA oral
No existen ensayos clínicos directos que demuestren que la suplementación con GABA oral reduzca el dolor de la fibromialgia.
Aunque se ha relacionado la disfunción del sistema GABAérgico con la fibromialgia, incluyendo concentraciones reducidas de GABA en la ínsula y alteraciones de los receptores GABA-A, estos hallazgos se refieren al sistema endógeno de neurotransmisores y no a los suplementos orales.
Una revisión sistemática del GABA oral encontró evidencia limitada para reducir el estrés y evidencia muy limitada e inconsistente respecto a sus beneficios para el sueño.
El GABA oral podría atravesar de manera limitada la barrera hematoencefálica, por lo que no está claro si la suplementación alcanza concentraciones clínicamente significativas en el sistema nervioso central.
Los medicamentos recetados que influyen en las vías relacionadas con GABA, como pregabalina o oxibato de sodio, han demostrado actividad en la fibromialgia, pero son farmacológicamente diferentes de los suplementos de GABA disponibles sin receta.
L-Teanina
No existen ensayos clínicos que hayan evaluado específicamente la L-teanina para la fibromialgia. Sin embargo, podría ayudar indirectamente con algunos síntomas asociados.
Sueño: Un metaanálisis de 18 ensayos aleatorizados con 897 participantes encontró mejorías en la calidad subjetiva del sueño, el tiempo para conciliarlo y la disfunción durante el día. Las dosis aproximadas de 200–450 mg diarios parecieron eficaces y generalmente bien toleradas.
Estrés y ansiedad: Un metaanálisis de 31 ensayos aleatorizados encontró efectos inconsistentes y estadísticamente no significativos sobre la ansiedad, aunque se informó una reducción modesta del estrés agudo.
Cognición: Una dosis única de 200 mg mejoró la atención y el tiempo de reacción en algunos estudios, lo que teóricamente podría ayudar a los pacientes que presentan “niebla mental” asociada con la fibromialgia.
Seguridad: No se identificaron eventos adversos graves en los estudios incluidos.
La L-teanina puede considerarse un complemento de bajo riesgo para las alteraciones del sueño, pero no existe evidencia de que reduzca directamente el dolor de la fibromialgia.
CBD y productos derivados del cannabis
La evidencia sobre el CBD y los productos derivados del cannabis está relativamente desarrollada, pero continúa siendo contradictoria.
Un ensayo aleatorizado doble ciego informado en 2026, con 200 participantes, comparó CBD a una dosis de 50 mg diarios con placebo durante 24 semanas. Según lo informado, el placebo produjo una mayor reducción del dolor que el CBD, con una diferencia de 0.7 puntos a favor del placebo. La fuente y los resultados numéricos deben verificarse independientemente.
Los productos derivados del cannabis que contienen THC han mostrado resultados más favorables en estudios observacionales. Un metaanálisis de 12 estudios con 1,248 participantes encontró una reducción de la intensidad del dolor; sin embargo, la evidencia fue clasificada como de baja calidad y estuvo impulsada principalmente por estudios observacionales, no por ensayos aleatorizados.
Un estudio de registro del Reino Unido que incluyó a 497 pacientes con fibromialgia tratados con productos medicinales derivados del cannabis informó mejorías en el dolor, la ansiedad, el sueño y la calidad de vida. No obstante, aproximadamente el 46% de los participantes presentó eventos adversos, principalmente fatiga.
Por lo tanto, los productos derivados del cannabis deben considerarse opciones complementarias individualizadas y no tratamientos establecidos de primera línea.
Fibromyalgia: Evidence-Based Treatment and Supplement Review
Established Treatment
AAFP guidance recommends aerobic exercise as the nonpharmacologic intervention with the strongest evidence, combined with cognitive behavioral therapy and, when clinically indicated, pharmacotherapy such as duloxetine, pregabalin, or amitriptyline.
A large systematic review and meta-analysis published in JAMA Internal Medicine found high-quality evidence supporting cognitive behavioral therapy for short-term pain reduction and antidepressants and central nervous system depressants for medium-term improvements in pain and quality of life.
A network meta-analysis found that amitriptyline was associated with the greatest improvements in sleep, fatigue, and quality of life, whereas duloxetine produced the greatest reductions in pain and depressive symptoms.
Supplements
Several supplements have stronger supporting evidence than oral GABA, L-theanine, or CBD for fibromyalgia symptom management. The better-supported options include coenzyme Q10, magnesium, vitamin D, melatonin, S-adenosylmethionine, acetyl-L-carnitine, and probiotics. However, none are considered first-line treatments, and the overall evidence quality remains moderate at best.
Coenzyme Q10
Coenzyme Q10 has some of the most consistent randomized controlled trial data among supplements. In one trial, 300 mg daily for 40 days significantly reduced pain, fatigue, and morning tiredness compared with placebo.
A crossover study using 200 mg twice daily reported approximately 24%–37% improvement in pain outcomes and a 22% reduction in fatigue.
Coenzyme Q10 added to pregabalin also significantly reduced pain and anxiety compared with pregabalin alone, suggesting a possible role as an adjunct to standard pharmacotherapy.
Magnesium
Magnesium citrate at 300 mg daily for eight weeks significantly reduced tender-point counts, tender-point index scores, Fibromyalgia Impact Questionnaire scores, and depression scores in a randomized trial of 60 patients.
The combination of magnesium and amitriptyline improved all measured parameters and outperformed either intervention alone.
Patients with fibromyalgia have frequently demonstrated lower serum or erythrocyte magnesium concentrations, with lower levels correlating with greater pain, sleep disturbance, and functional impairment.
Evidence supporting magnesium for chronic pain overall remains inconclusive, although fibromyalgia-specific findings are more encouraging.
Vitamin D
Vitamin D findings are mixed. One randomized trial reported that correcting vitamin D deficiency with 1,200–2,400 IU daily for 25 weeks significantly reduced visual analog scale pain scores and morning fatigue.
Another trial using 50,000 IU weekly for 12 weeks found no significant improvement in pain or Fibromyalgia Impact Questionnaire scores.
A meta-analysis of eight trials involving 694 participants found improvements in physical function and Fibromyalgia Impact Questionnaire scores but no significant improvement in visual analog scale pain scores.
Vitamin D supplementation is therefore most likely to benefit patients with documented deficiency.
Melatonin
Melatonin at 3–6 mg at bedtime improved pain, sleep, tender-point counts, and Fibromyalgia Impact Questionnaire scores across several fibromyalgia trials.
A 2026 systematic review of melatonin for musculoskeletal pain found modest improvements in chronic pain and sleep quality, although the changes did not consistently meet minimal clinically important difference thresholds.
Melatonin is best considered an adjunct for patients with sleep-predominant fibromyalgia symptoms.
Oral GABA
There is no direct clinical trial evidence demonstrating that oral GABA supplementation reduces fibromyalgia pain.
Although GABAergic dysfunction has been implicated in fibromyalgia, including reduced insular GABA concentrations and altered GABA-A receptor activity, these findings concern the endogenous neurotransmitter system rather than oral supplements.
A systematic review of oral GABA found limited evidence for stress reduction and very limited, inconsistent evidence for improved sleep.
Oral GABA may have limited blood-brain barrier penetration, making it uncertain whether supplementation produces clinically meaningful central nervous system concentrations.
Prescription medications that influence GABA-related pathways, such as pregabalin or sodium oxybate, have demonstrated activity in fibromyalgia, but they are pharmacologically distinct from over-the-counter GABA supplements.
L-Theanine
No clinical trials have specifically evaluated L-theanine for fibromyalgia. It may, however, indirectly address selected associated symptoms.
Sleep: A meta-analysis of 18 randomized trials involving 897 participants found improvements in subjective sleep quality, sleep-onset latency, and daytime dysfunction. Doses of approximately 200–450 mg daily appeared effective and generally well tolerated.
Stress and anxiety: A meta-analysis of 31 randomized trials found inconsistent and statistically nonsignificant effects on anxiety, although a modest reduction in acute stress was reported.
Cognition: A single 200 mg dose improved attention and reaction time in some studies, which could theoretically help patients experiencing “fibro fog.”
Safety: No serious adverse events were identified across the included trials.
L-theanine may be considered a low-risk adjunct for sleep disturbance, but there is no evidence that it directly reduces fibromyalgia pain.
CBD and Cannabis-Based Products
Evidence regarding CBD and cannabis-based products is comparatively developed but remains conflicting.
A reported 2026 double-blind randomized trial involving 200 participants compared CBD 50 mg daily with placebo for 24 weeks. Placebo reportedly produced a greater reduction in pain than CBD, with a between-group difference of 0.7 points favoring placebo. This source and its numerical findings should be independently verified.
Cannabis-based products containing THC have shown more favorable results in observational research. A meta-analysis of 12 studies involving 1,248 participants found a reduction in pain intensity, but the evidence was graded as low quality and was driven primarily by observational rather than randomized studies.
A UK registry study of 497 patients with fibromyalgia treated with cannabis-based medicinal products reported improvements in pain, anxiety, sleep, and quality of life. However, approximately 46% of participants reported adverse events, most commonly fatigue.
Cannabis-based products should therefore be regarded as individualized adjunctive options rather than established first-line treatments.
FAQ - INTERVENTIONAL PAIN MANAGEMENT
FAQ: Interventional Pain Services
What is interventional pain management?
Interventional pain management is a medical specialty that uses targeted procedures, diagnostic testing, and coordinated treatment plans to help identify the source of pain, reduce symptoms, improve function, and support recovery. It is often used along with conservative care, medications, rehabilitation, and other medical or surgical evaluations when appropriate.
Why might my doctor recommend interventional pain services?
Your doctor may recommend a pain procedure, additional diagnostic testing, and/or other treatments to help reduce pain, improve movement, and support your recovery. These treatments are often used with conservative care, such as home exercises, physical therapy, chiropractic care, medications, activity modification, and follow-up with your treating doctors.
What is an occipital nerve block?
An occipital nerve block is an injection near the nerves at the back of the head. It may be recommended for headaches, occipital neuralgia, or pain that starts in the upper neck and travels toward the scalp.
What is a facet joint injection or medial branch block?
Facet procedures target the small joints of the spine or the nerves that carry pain from those joints. They may be recommended for neck, mid-back, or low back pain that worsens with extension, rotation, posture, or activity.
What is radiofrequency ablation?
Radiofrequency ablation, also called RFA, uses heat from radiofrequency energy to reduce pain signals from targeted nerves. It may be recommended when diagnostic facet or joint-related blocks provide meaningful temporary relief and longer-lasting relief is desired.
What is an epidural steroid injection?
An epidural injection places anti-inflammatory medication near irritated spinal nerves. It may be recommended for neck, back, arm, or leg pain caused by disc herniation, stenosis, or nerve-root inflammation.
What are joint and bursa injections?
Joint or bursa injections may be recommended for painful inflammation or injury involving areas such as the sacroiliac joint, hip, knee, wrist, shoulder, or bursa. These injections may help reduce pain, improve motion, and support daily activity.
What other diagnostics or treatments may be recommended?
Your doctor may also recommend additional testing or treatment options, depending on your symptoms, exam findings, imaging, and response to care. These may include EMG/NCT testing to evaluate nerve function, bracing for the neck, back, or joints, additional physical therapy and/or chiropractic care, lifestyle modifications, medication review, updated imaging, or consultation with other specialists.
What are the goals of these procedures?
Your doctor may recommend a procedure to help identify the pain source, reduce inflammation, decrease pain intensity, improve function, and help you participate more comfortably in rehabilitation. The goal is not always to cure the condition, but to improve pain control, activity tolerance, and quality of life.
What should I expect during a pain procedure?
Most procedures are performed using sterile technique and may use imaging guidance, such as fluoroscopy or ultrasound. Local anesthetic may be used to numb the area. Some patients feel improvement quickly, while others notice gradual improvement over several days. Relief may be temporary, partial, or longer lasting depending on the condition and treatment response.
What should I tell my medical team before a procedure?
Tell your medical team if you take blood thinners, have diabetes, have an infection, are pregnant, have allergies to medications or contrast dye, or have had a prior reaction to steroids or anesthesia. All procedures have risks, including bleeding, infection, increased pain, allergic reaction, nerve injury, medication side effects, or incomplete relief. Your doctor will review the risks, benefits, and alternatives before treatment.
What should I do after the procedure?
Follow your post-procedure instructions carefully. Avoid strenuous activity until cleared. Track your pain relief, activity tolerance, and any changes in symptoms. Contact the office or seek urgent care for fever, severe headache, new weakness, loss of bowel or bladder control, chest pain, shortness of breath, or worsening neurologic symptoms.
Why is follow-up important?
Your follow-up visit helps determine how well the treatment worked and whether additional care is needed. Your doctor may recommend continued conservative care, repeat injection, RFA, further testing, specialist referral, or other treatment options based on your response.
Technology for Neuropathy
Teaching Opioid Alternatives
Breast Cancer & Med Cannabis (Basic)
Breast Cancer & Med Cannabis (Advanced)
INJECTION VIDEOS
CERVICAL FACET | CERIVICAL MEDIAL BRANCH BLOCK (MBB) -> CERIVICAL RFA
THORACIC = EPIDURAL HERNIATED DISC KYPHOSIS
LUMBAR FACET LUMBAR MEDIAL BRANCH BLOCK -> LUMBAR RFA
NERVE BLOCKS / TRIGGER POINT:
VIDEOS: PAIN | VIEWMEDICA VIDEOS | PAIN MANAGEMENT
KNEE:
HYALGAN® Injection for Knee Pain (Fluoroscopic Guided)
Talking to Your Doctor About Medications
Managing Pain After Surgery (At Home) Ibuprofen
MEDICAL MARIJUANA Using Opioids Safely Narcan® Nasal Spray (Naloxone)
Exercising With Chronic Pain Preventing Back Pain Diabetes and Exercise
Anti-Inflammatory Diet Intermittent Fasting Keto Diet Mediterranean Diet
Paleo Diet Vegan Diet DASH Diet Dietary Fiber
HANDOUTS [MEDICAL]
Other Healthy Foods ...
A
Almonds: Provide Vitamin E, magnesium, and protein.
Avocado: Pack healthy monounsaturated fats and potassium.
Asparagus: Deliver chromium, fiber, and folate.
B
Broccoli: High in sulforaphane, fiber, and Vitamin C.
Blueberries: Loaded with antioxidants and low-glycemic carbohydrates.
Black Beans (Dry/Boiled): Packed with plant protein, fiber, and iron.
C
Chicken Breast: Packed with lean protein and selenium.
Citrus Fruits (Oranges/Limes): Lactose-free choice providing Vitamin C to lower cortisol.
Cherries: Rich in anthocyanins to reduce muscle soreness and inflammation.
D
Dark Leafy Greens: Provide iron, magnesium, and nitrates.
Dark Chocolate (85%+): Supplies magnesium, antioxidants, and healthy fats.
E
Eggs: Ultimate source of leucine, protein, and healthy fats.
Edamame (Fresh/Frozen): Offers plant-based protein, iron, and fiber.
F
Fish (Fresh/Frozen): Supplies ultra-lean protein and omega-3 fatty acids.
Salmon: Boosts fat loss via omega-3s.
Tuna: High-density lean protein source.
Cod: Low-calorie, pure muscle-building protein.
Flaxseeds: High in lignans, fiber, and alpha-linolenic acid.
Need a presentation or education?
Anesthesia Pain Topics
Opioid Alternatives - Pain Diagnosis
Medical Cannabis - Pain Treatments
Contact: DrTerelNewton@gmail.com
Disclaimer: Information provided is for reference only and does not imply affiliation or endorsement with the mentioned individuals, companies, products, services, treatments, and websites. For informational purposes only - contact your medical provider for health and medical advice. Content accuracy, completeness, and timeliness are not guaranteed. Inclusion of information and websites does not constitute endorsement. Users should exercise caution when accessing external content. The third party links are not under our controlled and we do not monitor them so we cannot be responsible for any damages from using those links. See your medical, legal, finance, tax, spiritual and other professionals for discussion, guidance, planning, recommendations and greater understanding of the risks, benefits, options and ability to apply any information to your situation.
DISCUSS WITH YOUR DOCTOR 1ST ( Blood thinners | English )
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022307s002lbl.pdf
The half-life of Effient (prasugrel) is approximately 7 hours (range 2–15 hours), based on the elimination half-life of its active metabolite.[1] This is substantially shorter than the half-life of warfarin (36–48 hours), and also shorter than the half-lives of the direct oral anticoagulants previously discussed: dabigatran (12–17 hours), apixaban (9–14 hours), rivaroxaban (5–13 hours depending on age), and betrixaban (19–27 hours).[1-6]
**** Important Reminder - FOR REFERENCE ONLY
SEEK INSTRUCTIONS FROM YOUR DOCTORS ****
***For Spine AND HIP INJECTIONS - here are instructions to stop bloodthinners.
For SI joint injections - no need to stop your blood thinner.
Do not stop taking your anticoagulant until you have been cleared to do so by the medical provider prescribing that medication.
Anticoagulants
Coumadin (warfarin): Stop 5 days before procedure; INR must be obtained on the day of the procedure.
Pradaxa (dabigatran): Stop 4 days before procedure.
Eliquis (apixaban): Stop 3 days before procedure.
Xarelto (rivaroxaban): Stop 3 days before procedure.
Bevyxxa (betrixaban): Stop 6 days before procedure.
Antiplatelets / Platelet Inhibitors
Aspirin / Excedrin (any dose “baby” or otherwise): Stop 7 days before procedure.
Plavix (clopidogrel): Stop 7 days before procedure.
Effient (prasugrel): Stop 10 days before procedure.
Ticlid (ticlopidine): Stop 5 days before procedure.
Pletal (cilostazol): Stop 2 days before procedure.
NSAIDs (Nonsteroidal Anti-inflammatory Drugs)
Advil (ibuprofen): Stop 1 day before procedure.
Arthrotec (diclofenac): Stop 1 day before procedure.
Indomethacin: Stop 2 days before procedure.
Lodine (etodolac): Stop 2 days before procedure.
Mobic (meloxicam): Stop 4 days before procedure.
Aleve (naproxen): Stop 4 days before procedure.
Relafen (nabumetone): Stop 6 days before procedure.
Feldene (piroxicam): Stop 10 days before procedure.
Supplements
Fish oil: Stop 6 days before procedure.
Garlic: Stop 7 days before procedure.
Vitamin E: Stop 7 days before procedure.
Turmeric: Stop 7 days before procedure.
Again, confirm these timelines with the provider who prescribed your medication.
**** Recordatorio importante - SOLO PARA REFERENCIA
BUSQUE INSTRUCCIONES DE SU MÉDICO ****
Para inyecciones en la columna vertebral Y la cadera – aquí están las instrucciones para suspender anticoagulantes.
Para inyecciones en la articulación sacroilíaca (SI) – no es necesario suspender su anticoagulante.
No deje de tomar su anticoagulante hasta que haya sido autorizado por el proveedor médico que le recetó ese medicamento.
Anticoagulantes
Coumadin (warfarina): Suspenda 5 días antes del procedimiento; el INR debe obtenerse el día del procedimiento.
Pradaxa (dabigatrán): Suspenda 4 días antes del procedimiento.
Eliquis (apixabán): Suspenda 3 días antes del procedimiento.
Xarelto (rivaroxabán): Suspenda 3 días antes del procedimiento.
Bevyxxa (betrixabán): Suspenda 6 días antes del procedimiento.
Antiplaquetarios / Inhibidores de Plaquetas
Aspirina / Excedrin (cualquier dosis “baja” o normal): Suspenda 7 días antes del procedimiento.
Plavix (clopidogrel): Suspenda 7 días antes del procedimiento.
Effient (prasugrel): Suspenda 10 días antes del procedimiento.
Ticlid (ticlopidina): Suspenda 5 días antes del procedimiento.
Pletal (cilostazol): Suspenda 2 días antes del procedimiento.
AINEs (Antiinflamatorios No Esteroides)
Advil (ibuprofeno): Suspenda 1 día antes del procedimiento.
Arthrotec (diclofenaco): Suspenda 1 día antes del procedimiento.
Indometacina: Suspenda 2 días antes del procedimiento.
Lodine (etodolaco): Suspenda 2 días antes del procedimiento.
Mobic (meloxicam): Suspenda 4 días antes del procedimiento.
Aleve (naproxeno): Suspenda 4 días antes del procedimiento.
Relafen (nabumetona): Suspenda 6 días antes del procedimiento.
Feldene (piroxicam): Suspenda 10 días antes del procedimiento.
Suplementos
Aceite de pescado: Suspenda 6 días antes del procedimiento.
Ajo: Suspenda 7 días antes del procedimiento.
Vitamina E: Suspenda 7 días antes del procedimiento.
Cúrcuma: Suspenda 7 días antes del procedimiento.
IMPORTANT CALCULATIONS ML TO OZ (FL) 5ML=1TSP 250ML = 1 CUP CM TO INCHES MILES TO KM
FAVORITE
RESOURCES:
FAQ - Why vital signs matter...
Vital signs matter because they are the earliest and most reliable objective indicators of physiologic stability or deterioration, serving as the foundation for safe procedural decision-making. In the context of an interventional pain clinic, each vital sign provides specific, actionable clinical information:
Blood Pressure — Reflects cardiovascular reserve and end-organ perfusion. Uncontrolled hypertension (preoperative diagnosis) is associated with a 35% increase in cardiovascular complications in a meta-analysis of 30 observational studies.
Intraoperative hypotension (MAP <65 mm Hg or SBP <90 mm Hg for ~15 minutes) is associated with postoperative myocardial injury, acute kidney injury, and mortality.
In a Vanderbilt study of 57,389 elective procedures, the relationship between preoperative blood pressure and adverse events was U-shaped — risk increased both above SBP 173 mm Hg and below SBP 93 mm Hg.
Uncontrolled hypertension also increases myocardial oxygen demand via elevated LV end-diastolic pressure, leading to subendocardial ischemia, and increases the risk of cerebrovascular events and bleeding.
Heart Rate — Detects arrhythmias, autonomic dysfunction, and hemodynamic compromise. Tachyarrhythmias or bradyarrhythmias associated with hypotension are considered active cardiac conditions that are generally contraindications to elective procedures.
Heart rate monitoring is also critical because vasovagal reactions are the most common adverse event during interventional pain procedures, occurring in 1.1–2.6% of cases across large multi-institutional studies of over 26,000 and 8,000 procedures respectively.
These reactions involve reflex bradycardia and hypotension that, if unrecognized, can rarely progress to asystole.
Oxygen Saturation — Detects hypoxemia before clinical cyanosis becomes apparent. Sedative and analgesic agents used during procedures can cause respiratory depression, and early detection via pulse oximetry enables timely intervention. In the POISE-2 trial, more than 40% of patients had postoperative SBP <90 mm Hg, and a study of continuous monitoring found that >90% of prolonged desaturation episodes (SpO₂ <90% for a continuous hour) were missed by routine intermittent nursing assessments.
The ASA Task Force on Moderate Procedural Sedation states that regular monitoring of vital signs reduces the likelihood of adverse outcomes during both moderate and deep sedation.
Respiratory Rate — Often called the most sensitive early predictor of clinical deterioration. Abnormal respiratory rate is an independent predictor of adverse events, and changes in respiratory rate are observable in documented vital signs 1–4 hours prior to cardiac arrest.
Respiratory rate is particularly important in the pain clinic setting because opioid-tolerant patients receiving additional sedation or anxiolytics are at risk for ventilatory depression.
Temperature — Identifies active infection, which is a contraindication to procedures involving neuraxial injections, joint injections, or device implantation due to the risk of seeding an infection into the procedural site. Hypothermia signals potential hemodynamic instability, sepsis, or metabolic derangement.
Blood Glucose — Identifies metabolic instability. Severe hypoglycemia (<54 mg/dL) causes neuroglycopenia with altered mental status, seizures, and loss of consciousness — all of which compromise patient safety and the ability to provide procedural feedback. Severe hyperglycemia (>400 mg/dL) may indicate DKA or HHS, which carry significant morbidity and mortality if a procedure is performed without recognition and treatment.
The Overarching Principle
Vital signs represent the simplest, cheapest, and most widely accepted signs of clinical change and are the core component of early warning systems.
The Society of Critical Care Medicine (2023) emphasizes that clinical deterioration leads to measurable changes from baseline conditions, with severity reflected by the degree of vital sign changes.
In the procedural setting specifically, sedative and analgesic agents may blunt appropriate autonomic compensation for hypovolemia and procedure-related stresses, while inadequate sedation can trigger harmful autonomic stress responses (hypertension, tachycardia).
Vital sign monitoring bridges this gap by enabling real-time detection and intervention.
Evidence from large databases demonstrates that up to 20–30% of hospital ward patients receive substandard care prior to ICU admission, with up to 70% of adverse events being potentially avoidable — largely due to missed, misinterpreted, or mismanaged vital sign changes.
In the interventional pain clinic, where procedures are performed on an outpatient basis without the safety net of prolonged postoperative monitoring, pre-procedure vital sign assessment serves as the primary gatekeeper for identifying patients whose physiologic status places them at unacceptable risk.
FAQ - Why vital signs matter... [ Part 2 ]
I. Blood Pressure
A. Generally Acceptable
90–179/60–109 mm Hg
Patient asymptomatic
Stable compared with baseline
Note: The 2024 AHA/ACC Perioperative Guidelines indicate little evidence for increased perioperative risk at blood pressure below 180/110 mm Hg in the absence of Revised Cardiac Risk Index components (coronary artery disease, heart failure, cerebrovascular disease, creatinine greater than 2.0 mg/dL, insulin-dependent diabetes)
[1]
B. Reassess Before Proceeding
Systolic 180–199 mm Hg or diastolic 110–119 mm Hg without cardiovascular risk factors
Systolic 90–99 mm Hg
Repeat after rest and assess pain, anxiety, hydration, medication adherence, and baseline blood pressure
Elective procedures should not be cancelled based solely upon a preoperative arterial pressure value; clinical context must be considered
[2]
C. Usually Unacceptable for Elective Procedures
Systolic blood pressure ≥180 mm Hg and/or diastolic blood pressure ≥110 mm Hg with cardiovascular risk factors, persistent after reassessment
Systolic blood pressure less than 90 mm Hg
Mean arterial pressure less than 60–65 mm Hg
Blood pressure ≥180 and/or ≥120 mm Hg with concerning symptoms (headache, visual changes, chest pain, dyspnea) requires emergency evaluation for hypertensive crisis; note that either value alone qualifies
[1]
II. Heart Rate
A. Generally Acceptable
50–100 beats per minute
Regular rhythm or documented stable chronic rhythm (e.g., rate-controlled atrial fibrillation)
Asymptomatic sinus bradycardia of 45–49 beats per minute may be acceptable in conditioned athletes or patients on beta-blocker therapy
B. Reassess Before Proceeding
40–49 beats per minute
101–120 beats per minute
Repeat measurement and consider ECG
Evaluate for pain, anxiety, dehydration, fever, medication effect
C. Usually Unacceptable
Persistent heart rate less than 40 beats per minute
Persistent heart rate greater than 120 beats per minute
New irregular rhythm not previously documented
High-grade heart block
Associated syncope, chest pain, dyspnea, or hypotension
III. Respiratory Rate
A. Generally Acceptable
12–24 breaths per minute
Unlabored breathing
B. Reassess Before Proceeding
10–11 breaths per minute
25–29 breaths per minute
Evaluate for anxiety, pain, opioids, sedatives, or pulmonary disease
C. Usually Unacceptable
Respiratory rate less than 10 breaths per minute (pre-procedure, before any sedation)
Respiratory rate 30 breaths per minute or greater
Apnea or shallow breathing
Accessory muscle use
Altered mental status
Inability to speak in full sentences
IV. Oxygen Saturation
A. Generally Acceptable
SpO₂ 94% or greater on room air
SpO₂ 88–92% may be acceptable when this is the documented target for COPD or chronic hypercapnic respiratory disease
B. Reassess Before Proceeding
SpO₂ 90–93% in a patient without known chronic lung disease
Significant decrease from documented baseline (even if above 90%)
Confirm waveform quality and probe placement
C. Usually Unacceptable
SpO₂ less than 90% without a documented chronic baseline at that level
Oxygen saturation below prescribed target despite supplemental oxygen
New or increasing oxygen requirement
Cyanosis or respiratory distress
V. Temperature
A. Generally Acceptable
36.0–37.9°C (96.8–100.2°F)
No systemic symptoms
B. Reassess Before Proceeding
Borderline elevation (37.5–37.9°C or 99.5–100.2°F) with recent infection, chills, or current antibiotic use
Unexpectedly low temperature (35.5–35.9°C or 95.9–96.7°F)
C. Usually Unacceptable
Temperature 38.0°C (100.4°F) or greater with suspected or confirmed infection; defer and evaluate infection source, especially before neuraxial injections, joint injections, or device implantation
[3]
Temperature less than 35.5°C (95.9°F) with illness, hemodynamic instability, or altered mental status
VI. Blood Glucose
Note: The Society for Ambulatory Anesthesia (2024) states there are insufficient data to recommend a specific blood glucose level above which elective ambulatory surgery should be postponed. The thresholds below represent a practical framework derived from ADA, Endocrine Society, and SAMBA guidelines.
[4-5]
A. Generally Acceptable
80–180 mg/dL (ideal preprocedural target per ADA and Endocrine Society)
B. Reassess or Treat
70–79 mg/dL: treat with oral glucose, recheck in 15 minutes; proceed only when 80 mg/dL or greater and stable
181–250 mg/dL: may proceed for short procedures if long-term control is adequate (HbA1c less than 8%), no ketones, and patient is asymptomatic; administer correctional insulin and recheck in 1–2 hours
C. Caution — Strongly Consider Deferral
251–400 mg/dL: check for ketones (urine or serum); if negative and patient is asymptomatic with adequate long-term control, may proceed for short clinic procedures with insulin correction on a case-by-case basis; for ambulatory surgery center procedures, strongly consider deferral
Note: Preoperative glucose 200 mg/dL or greater has been associated with greater than 2-fold higher all-cause mortality in noncardiac surgery
[1]
D. Usually Unacceptable
Less than 70 mg/dL until treated and glucose is stable at 80 mg/dL or greater
Less than 54 mg/dL: clinically significant hypoglycemia requiring emergent treatment
Greater than 400 mg/dL: defer and evaluate urgently for diabetic ketoacidosis or hyperosmolar hyperglycemic state (check ketones, basic metabolic panel, anion gap)
Any glucose level associated with ketones, vomiting, dehydration, acidosis, altered mental status, diabetic ketoacidosis, or hyperosmolar hyperglycemic state
E. Preoperative HbA1c
Target less than 8% within 3 months of elective procedure (recommended but not mandatory for cancellation; postponing surgery based on HbA1c alone is not recommended per ADA 2026 and AHA/ACC 2024)
[1][5]
VII. Office Clinic Setting
A. Appropriate Cases
Stable vital signs within parameters above
Local anesthesia or minimal anxiolysis (e.g., oral benzodiazepine, nitrous oxide)
No evidence of acute cardiopulmonary or metabolic instability
B. Reasons to Defer
Persistent blood pressure ≥180 and/or ≥110 mm Hg with cardiovascular risk factors
Systolic blood pressure less than 90 mm Hg or mean arterial pressure less than 60–65 mm Hg
Significant arrhythmia (new or hemodynamically significant)
SpO₂ less than 90% without documented chronic baseline
Respiratory distress
Temperature 38.0°C (100.4°F) or greater with suspected infection
Blood glucose less than 70 mg/dL or greater than 400 mg/dL
Altered mental status
VIII. Ambulatory Surgery Center Setting
A. Additional Capabilities
Monitored anesthesia care
General anesthesia
Advanced airway equipment
Continuous monitoring (ECG, pulse oximetry, capnography, blood pressure)
Intravenous medications and vasopressors
Prolonged postoperative observation
B. Conditions That Remain Unacceptable for Elective Procedures
Hemodynamic instability (systolic blood pressure less than 90 mm Hg, mean arterial pressure less than 60–65 mm Hg)
Persistent severe uncontrolled hypertension (≥180 and/or ≥120 mm Hg) with end-organ symptoms
Significant untreated arrhythmia
Acute coronary syndrome
Acute stroke or transient ischemic attack
Active respiratory compromise or persistent hypoxemia
Diabetic ketoacidosis or hyperosmolar hyperglycemic state
Active systemic infection or sepsis
IX. Symptoms That Override Numeric Values
Urgent evaluation is required regardless of vital sign values for:
Chest pain or pressure
Acute shortness of breath
Focal neurologic deficit
Syncope or presyncope
Confusion or altered mental status
Cyanosis
Severe headache with neurologic symptoms
Signs of diabetic ketoacidosis or hyperosmolar hyperglycemic state (nausea, vomiting, abdominal pain, Kussmaul breathing, fruity breath, dehydration)
Anaphylaxis signs (urticaria, angioedema, wheezing with hypotension)
Active bleeding or signs of hemorrhage
Acute abdominal pain with hemodynamic instability
X. Discharge Criteria (Post-Procedure)
Discharge requires meeting all of the following:
Blood pressure and heart rate within 20% of preoperative baseline
SpO₂ at baseline or 92% or greater on room air
Awake, alert, and oriented (or at patient's baseline mental status)
Pain controlled (numeric rating scale 4 or less, or acceptable to patient)
Nausea and vomiting minimal or absent
Able to ambulate without dizziness (or at baseline mobility)
Minimal procedural bleeding
For diabetic patients: blood glucose 80 mg/dL or greater and able to tolerate oral intake before discharge
Disclaimer: Information provided is for reference only and does not imply affiliation or endorsement with the mentioned individuals, companies, products, services, treatments, and websites. For informational purposes only - contact your medical provider for health and medical advice. Content accuracy, completeness, and timeliness are not guaranteed. Inclusion of information and websites does not constitute endorsement. Users should exercise caution when accessing external content. The third party links are not under our controlled and we do not monitor them so we cannot be responsible for any damages from using those links. See your medical, legal, finance, tax, spiritual and other professionals for discussion, guidance, planning, recommendations and greater understanding of the risks, benefits, options and ability to apply any information to your situation.